Introduction {#s1}
============

Japan, a country that has successfully achieved good population health[@bib_001]^)^, is now facing new challenges caused by a rapidly aging population[@bib_002]^)^. Statistics in Japan suggest that the proportion of people aged 75 and over will exceed 25% until 2025[@bib_003]^)^, whereas the proportion of the working population will decrease[@bib_003]^)^. Given that these situations may threaten the sustainability of economic growth and health insurance[@bib_004]^)^, there is an urgent need to develop effective strategies to overcome these issues. One promising solution is prolonging working life and emphasizing health promotion among workers[@bib_005]^)^. For effective health promotion, it is important to understand the current health status of middle-aged and older Japanese workers.

To date, few studies have shown the age- and sex-specific prevalence of cardiovascular risk factors in middle-aged and older workers in Japan. Suka *et al.*[@bib_006]^)^ recently reported a higher prevalence of hypertension, hyperlipidemia, diabetes, and obesity in male workers than female workers (n=approximately 120,000), and a high prevalence of these factors among middle-aged and older workers in both sexes. Similar results were shown for hypertension, hyperlipidemia, and diabetes in a national survey of 11,140 Japanese male and female workers[@bib_007]^)^. We also reported similar trends for diabetes and pre-diabetes in 55,000 male and female workers[@bib_008]^)^. In addition, descriptive data among Japanese workers are limited for metabolic syndrome[@bib_009]^)^, abdominal obesity[@bib_010], [@bib_011]^)^, underweight[@bib_011]^)^, physical activity[@bib_012], [@bib_013]^)^, and fitness[@bib_012]^)^, which would all be important factors for health management.

Providing updated and systematic data on diseases and their risk factors among Japanese workers---with a special emphasis on middle-aged and older workers---would lead to a better understanding of the current health situation and help develop effective strategies for health promotion in the occupational settings of Japan. Here, we show data on the age- and sex-specific prevalence of hypertension, diabetes, dyslipidemia, metabolic syndrome, obesity, underweight, abdominal obesity, and smoking among Japanese workers aged 20--69 years in 2014 using health checkup data from large-scale companies. Among subgroups, we also show data on leisure-time exercise in 2014 and cardiorespiratory fitness in 2012.

Participans and Methods {#s2}
=======================

Study settings
--------------

The present descriptive analyses were performed using cross-sectional data on periodic health checkups from the Japan Epidemiology Collaboration on Occupational Health (J-ECOH) Study, an on-going, large-scale multi-company based study among Japanese workers from more than 10 companies. In Japan, workers are obliged to undergo health examination at least once a year under the Industrial Safety and Health Act. The details of the J-ECOH Study[@bib_014]^)^ and sub-cohorts for analysis of fitness[@bib_015]^)^ and physical activity[@bib_016]^)^ have been described elsewhere. The J-ECOH Study was announced in each company using posters. Participants did not provide their verbal or written informed consent to take part in the study but were given an opportunity to refuse the use of their data for research, according to the Japanese Ethical Guidelines for Epidemiological Research. The study protocol was approved by the Ethics Committee of the National Center for Global Health and Medicine, Japan.

For analysis of data other than exercise and fitness, we extracted data on 91,150 workers (77,264 men and 13,886 women), aged 20--69, from 11 companies who received health checkups between April 2014 and March 2015 (in some companies, between January 2014 and December 2014). For analysis of leisure-time exercise, we used data on 50,864 workers (8,389 women) aged 20--69 who underwent their health checkups between April 2014 and March 2015 from one of the 11 participating companies[@bib_016]^)^. For cardiorespiratory fitness, we extracted data on 4,346 workers (810 women) aged 20--64 collected between January 2012 and December 2012 from another one of the participating companies[@bib_015]^)^.

Participants
------------

We excluded individuals who did not have data on target outcomes for respective analysis, which yielded different population sizes in each analysis, as shown in [Fig. 1](#fig_001){ref-type="fig"}. Excluded participants were 1,845 men and 278 women for hypertension; 20,126 men and 3,201 women for diabetes; 14,779 men and 2,415 women for dyslipidemia; 19,926 men and 3,137 women for metabolic syndrome; 12,853 men and 2,212 women for waist circumference; and 790 men and 36 women for BMI. For leisure-time exercise analysis, we excluded 5,526 men and 958 women who did not have data on leisure-time exercise or who engaged only in unspecified activity in one of the participating companies. For cardiorespiratory fitness, 889 men and 240 women were excluded in another one of the participating companies.Fig. 1.Sampling design.

General health examination
--------------------------

Body height and weight were measured at each company in accordance with a standard protocol. Body mass index (BMI) was calculated as weight (kg) divided by squared height (m). Blood pressures were measured using an automated sphygmomanometer. Smoking habits and treatment for hypertension, dyslipidemia, and diabetes were self-reported using a questionnaire. Biochemical measurements included plasma glucose, hemoglobin A1c (HbA1c), low-density lipoprotein (LDL)-cholesterol, high-density lipoprotein (HDL)-cholesterol, and triglycerides. Plasma glucose level was determined by enzamatic method in ten companies and glucose oxidase peroxidative electrode method in one company. HbA1c level was determined by latex agglutination immunoassay in eight companies, high-performance liquid chromatography method in two companies, and enzymatic method in one company. LDL-cholesterol, HDL-cholesterol, and triglycerides levels were estimated by enzymatic method in all participating companies. All laboratories involved in the health examinations in the participating companies have received sufficiently high scores (score \>95 out of 100 or rank A) from external quality control agencies, including National Federation of Industrial Health Organization, the Japan Medical Association, and Japanese Association of Laboratory Medical Technologists.

Diagnosis of disease
--------------------

Hypertension was defined as systolic blood pressure of ≥140 mm Hg, diastolic blood pressure of ≥90 mm Hg, or under treatment for hypertension. Dyslipidemia was defined as LDL-cholesterol of ≥140 mg/dL, HDL-cholesterol of \<40 mg/dL, fasting triglycerides of ≥150 mg/dL, or under treatment for dyslipidemia. Diabetes was defined as fasting plasma glucose of ≥126 mg/dL, HbA1c of ≥6.5%, or self-report (under treatment for diabetes and/or history of diabetes). Metabolic syndrome was defined according to the criteria of the joint interim statement[@bib_017]^)^ as the presence of any three or more of the following criteria: (1) high waist circumference for Asians: ≥90 cm in men and ≥80 cm in women; (2) high triglycerides: ≥150 mg/dL; (3) low HDL cholesterol: \<40 mg/dL in men, \<50 mg/dL in women; (4) high blood pressure: systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg; and (5) high fasting glucose: ≥100 mg/dL. Participants reporting current treatment for dyslipidemia, hypertension, or diabetes were considered to meet the criteria for high triglycerides, high blood pressure, and high fasting glucose, respectively, irrespective of the data measured at the checkups.

Measurement of cardiorespiratory fitness and leisure-time exercise
------------------------------------------------------------------

As an indicator of cardiorespiratory fitness, we assessed estimated VO~2max~. Estimated VO~2max~ was obtained by an incremental endurance exercise test using a bicycle ergometer (Aerobike 900 U, Combi, Tokyo, Japan) with three phases of three minutes duration each (a total of 9 minutes). Details of this fitness measurement has been described previously[@bib_015]^)^. Participants were divided into two levels of cardiorespiratory fitness based on the criteria by Ministry of Health, Labour, and Welfare, Japan[@bib_018]^)^: high cardiorespiratory fitness in men was defined as ≥39 mL/kg/min among individuals aged \<40 years, ≥35 mL/kg/min among individuals aged 40-\<60 years, and ≥32 mL/kg/min among individuals aged ≥60 years, whereas high cardiorespiratory fitness in women was defined as ≥33 mL/kg/min among individuals aged \<40 years, ≥30 mL/kg/min among individuals aged 40-\<60 years, and ≥26 mL/kg/min among individuals aged ≥60 years.

Weekly dose of leisure-time exercise expressed in metabolic equivalent (MET) hours was calculated using data on types, frequency, and duration of exercise or sports activities during leisure using a standard questionnaire as described elsewhere[@bib_016]^)^. Participants were categorized into four groups according to the dose of leisure-time exercise per week: no exercise (0 MET hours), low (\>0 to \<7.5 MET hours), medium (7.5 to \<15.0 MET hours), or high (≥15.0 MET-hours) in harmony with recommended dose of physical activity by World Health Organization[@bib_019]^)^.

Statistical analysis
--------------------

Data are shown as mean (standard deviation) for continuous variables and percentages for categorical variables.

Results {#s3}
=======

The crude prevalence of hypertension was 22.0% and 11.6% in men and women, respectively ([Table 1](#tbl_001){ref-type="table"}). The prevalence of hypertension increased linearly with advancing age, reaching 48.4% and 37.4% among men and women aged 60--69 years, respectively. A large increase was observed in both men and women aged 30--69 years.Table 1.Age- and sex-specific prevalence of smoking, diabetes, hypertension, dyslipidemia, metabolic syndrome, abdominal obesity, obesity, and underweight (n=67,823 to 90,324)CharacteristicsCategories of age (year)\<3030 to 3940 to 4950 to 59≥60All (20 to 69)Men, *n*11,77814,98924,36219,6176,51877,264Smoker36.938.337.634.230.136.1Fasting glucose, mg/dL91±1095±1499±17105±22109±22101±19HbA~1c~, %5.3±0.45.4±0.55.6±0.65.8±0.85.9±0.75.6±0.7Diabetes1.03.46.814.821.79.8SBP, mmHg118±12119±13121±14125±15129±16122±14DBP, mmHg68±973±1077±1180±1080±1076±11Hypertension3.68.219.637.048.422.0Fasting triglyceride, mg/dL92±78117±93130±104132±96127±92126±97LDL-cholesterol, mg/dL105±29119±30125±30124±30122±30121±31HDL-cholesterol, mg/dL56±1256±1456±1458±1558±1557±15Dyslipidemia29.244.750.351.247.847.7Metabolic syndrome3.611.120.331.136.823.2Waist circumference, cm77.8±9.181.7±9.784.0±9.484.7±8.784.6±7.983.5±9.3Waist circumference ≥90 cm9.717.623.524.623.821.9BMI, kg/m^2^22.7±3.723.6±3.824.1±3.623.9±3.223.7±2.923.7±3.5Weight status≥30.0 kg/m^2^4.85.96.34.32.85.225.0 to \<30.0 kg/m^2^15.921.826.427.726.724.323.0 to \<25.0 kg/m^2^17.921.625.026.427.323.818.5 to \<23.0 kg/m^2^54.246.439.839.341.143.3\<18.5 kg/m^2^7.24.32.62.32.23.5Women, *n*2,0512,8595,2192,93981813,886Smoker8.613.311.510.49.711.1Fasting glucose, mg/dL88±989±1092±1396±14100±1893±13HbA~1c~, %5.3±0.45.4±0.45.5±0.55.7±0.55.9±0.65.5±0.5Diabetes1.21.72.56.112.73.9SBP, mmHg108±11110±13114±16121±17127±18115±16DBP, mmHg63±867±1071±1175±1176±1170±11Hypertension0.73.49.323.137.411.6Fasting triglyceride, mg/dL61±3371±4575±5087±4898±5578±49LDL-cholesterol, mg/dL98±26105±28115±29130±31129±30116±31HDL-cholesterol, mg/dL68±1467±1469±1672±1768±1769±16Dyslipidemia12.415.022.742.747.327.1Metabolic syndrome1.45.28.421.136.712.7Waist circumference, cm70.7±7.474.7±9.076.3±9.677.9±10.079.0±9.576.2±9.6Waist circumference ≥80 cm10.324.930.439.045.531.4BMI, kg/m^2^20.9±3.221.5±3.722.0±3.822.3±3.822.7±3.521.8±3.7Weight status≥30.0 kg/m^2^2.43.64.44.84.24.025.0 to \<30.0 kg/m^2^7.010.012.514.118.711.923.0 to \<25.0 kg/m^2^8.111.213.215.619.612.918.5 to \<23.0 kg/m^2^62.558.456.353.848.456.7\<18.5 kg/m^2^20.116.813.611.79.214.6Data are shown as (%) for categorical variables and mean±standard deviation for continuous variables.

The crude prevalence of diabetes was 9.8% and 3.8% in men and women, respectively. The prevalence of diabetes increased with advancing age ([Table 1](#tbl_001){ref-type="table"}), reaching 21.7% and 12.7% among men and women aged 60--69 years, respectively. A large increase was observed in both men and women aged 40--59 years. A similar trend was observed for fasting glucose and HbA1c in both men and women.

The crude prevalence of dyslipidemia was 47.7% and 27.1% in men and women, respectively ([Table 1](#tbl_001){ref-type="table"}). In men, the prevalence of dyslipidemia increased with advancing age, reaching 51.2% in workers aged 50--59 years; the prevalence of dyslipidemia was slightly decreased in workers aged 60--69 years (47.8%). In women, the prevalence of dyslipidemia increased linearly with aging, reaching 47.3% in workers aged 60--69 years. Similar changes with aging were observed for triglycerides and LDL cholesterol. HDL cholesterol levels were not materially different by age group in both sexes.

The crude prevalence of metabolic syndrome, defined by the 2009 joint statement criteria, was 23.2% and 12.7% in men and women, respectively ([Table 1](#tbl_001){ref-type="table"}). The prevalence of metabolic syndrome increased with advancing age, reaching 36.8% and 36.7% in men and women aged 60--69 years, respectively. A large increase was observed in men aged 30--69 years and in women aged 40--69 years.

Regarding abdominal obesity, defined as a waist circumference ≥90 cm in men and ≥80 cm in women, the crude prevalence was 21.9% in men and 31.4% in women. In men, the prevalence of abdominal obesity increased with aging for workers aged 50--59 years (reaching 24.6%), and then slightly decreased in workers aged 60--69 years (reaching 23.8%). In women, the prevalence of abdominal obesity gradually increased with aging, reaching 45.5% in workers aged 60--69 years.

The crude prevalence of obesity (BMI ≥25.0 kg/m^2^) was 29.5% and 15.9% in men and women, respectively ([Table 1](#tbl_001){ref-type="table"}). In men, the prevalence of obesity increased with advancing age, reaching 32.7% in workers aged 40--49 years, then, the prevalence of obesity was slightly and gradually decreased in workers aged 50--69 years. In women, the prevalence of obesity increased linearly with aging; the highest prevalence of obesity was observed in workers aged 60--69 years (22.9%). Similar changes with aging were observed for mean BMI levels.

The crude prevalence of underweight (\<18.5 kg/m^2^) was 3.5% and 14.6% in men and women, respectively ([Table 1](#tbl_001){ref-type="table"}). The prevalence of underweight decreased with advancing age, reaching 2.2% and 9.2% in men and women aged 60--69 years, respectively.

The crude prevalence of smoking was 36.1% and 11.1% in women, respectively ([Table 1](#tbl_001){ref-type="table"}). In both sexes, the prevalence of smoking increased in workers aged 20--39 years; in men and women aged 60--69 years, the prevalence of smoking slightly but steadily decreased with aging, reaching 30.1% and 9.7%, respectively.

The crude prevalence of no leisure-time exercise was 62.3% and 77.0% in men and women, respectively ([Table 2](#tbl_002){ref-type="table"}). The prevalence of no leisure-time exercise increased in men aged 20--49 years, while in workers aged 60--69 years, the prevalence of no leisure-time exercise decreased with aging, reaching 54.8%. In women aged 20--39 years, the prevalence of no leisure-time exercise increased; however, the prevalence of no leisure-time exercise decreased with aging in workers aged 60--69 years, reaching 74.3%.Table 2.Weekly dose of leisure-time exercise by age and sex (n=44,380)CharacteristicsCategories of age (year)\<3030 to 3940 to 4950 to 59≥60All (20 to 69)Men, *n*5,4837,50611,8738,9733,15936,949Weekly exercise dose0 MET-hour2,982 (54.8)4,869 (64.9)7,709 (64.9)5,736 (63.9)1,732 (54.8)23,028 (62.3)\>0 to \<7.5 MET-hours1,215 (22.3)1,191 (15.9)1,718 (14.5)1,135 (12.7)420 (13.3)5,679 (15.4)7.5 to \<15.0 MET-hours632 (11.6)766 (10.2)1,245 (10.5)989 (11.0)401 (12.7)4,033 (10.9)≥15.0 MET-hours609 (11.2)680 (9.1)1,201 (10.1)1,113 (12.4)606 (19.2)4,209 (11.4)Women, *n*1,1341,6432,4921,5905727,431Weekly exercise dose0 MET-hour800 (70.6)1,328 (80.8)1,970 (79.1)1,195 (75.2)425 (74.3)5,718 (77.0)\>0 to \<7.5 MET-hours184 (16.2)181 (11.0)278 (11.2)205 (12.9)64 (11.2)912 (12.3)7.5 to \<15.0 MET-hours76 (6.7)68 (4.1)128 (5.1)91 (5.7)40 (7.0)403 (5.4)≥15.0 MET-hours74 (6.5)66 (4.0)116 (4.7)99 (6.2)43 (7.5)398 (5.4)Data are shown as number (%).

The crude prevalence of low cardiorespiratory fitness was 39.2% and 57.1% in men and women, respectively ([Table 3](#tbl_003){ref-type="table"}). In men, the prevalence of low fitness was 33.7%, 51.2%, 33.8%, 38.1%, and 18.1% in workers aged \<30, 30--39, 40--49, 50--59, and 60--64, respectively. In women, the corresponding values were 53.8%, 65.1%, 48.7%, 64.1%, and 33.3%, respectively.Table 3.Cardiorespiratory fitness level by age and sex (n=4,346)CharacteristicsCategories of age (year)\<3030 to 3940 to 4950 to 5960 to 64All (20 to 64)Men, *n*433719708707802,647High cardiorespiratory fitness*^a^*287 (66.3)351 (48.8)469 (66.2)438 (62.0)65 (81.3)1,610 (60.8)Low cardiorespiratory fitness146 (33.7)368 (51.2)239 (33.8)269 (38.1)15 (18.8)1,037 (39.2)Women, *n*1581091501533573High cardiorespiratory fitness*^b^*71 (54.2)38 (34.9)77 (51.3)55 (36.0)2 (66.7)246 (42.9)Low cardiorespiratory fitness84 (53.8)71 (65.1)73 (48.7)98 (64.1)1 (33.3)327 (57.1)Data are shown as number (%).*^a^* High cardiorespiratory fitness was defined as ≥39 mL/kg/min in individuals aged \<40 years, ≥35 mL/kg/min in individuals aged 40 to \<60 years, and ≥32 mL/kg/min in individuals aged ≥60 years.*^b^* High cardiorespiratory fitness was defined as ≥33 mL/kg/min in individuals aged \<40 years, ≥30 mL/kg/min in individuals aged 40 to \<60 years, and ≥26 mL/kg/min in individuals aged ≥60 years.

Discussion {#s4}
==========

The present study among Japanese workers aged 20--69 years from large-scale companies in Japan showed that the crude prevalence of cardiometabolic risk factors including hypertension, diabetes, dyslipidemia, metabolic syndrome, obesity, and abdominal obesity were 22.0%, 9.8%, 47.7%, 23.2%, 29.5%, and 21.9% in men, respectively, and 11.6%, 3.9%, 27.1%, 12.7%, 15.9%, and 31.4% in women, respectively. The prevalence of these factors increased overall with advancing age in both men and women. In contrast, the prevalence of underweight decreased linearly with increasing age in both men and women. The prevalence of smoking exceeded 30% in men regardless of age group, whereas smoking prevalence was around 10% in women. In both men and women, more than half of workers did not engage in leisure-time exercise regardless of age group.

In the present study, the prevalence of cardiometabolic risk factors including hypertension, dyslipidemia, diabetes, obesity defined by BMI, abdominal obesity defined by waist circumference, and metabolic syndrome increased with aging both in men and women. This finding is supported by previous studies among Japanese workers on hypertension[@bib_006], [@bib_007]^)^, dyslipidemia, diabetes[@bib_006], [@bib_007]^)^, obesity[@bib_006]^)^, waist circumference[@bib_010]^)^, and metabolic syndrome[@bib_009]^)^. The present findings, together with existing data of Japanese workers, suggest the importance of effective strategies for protecting cardiovascular health among middle-aged and older workers in Japan. A high-risk approach using a risk predicting score for cardiovascular disease[@bib_020]^)^ and/or a population-based approach to improve cardiovascular health[@bib_021]^)^ would serve such a purpose. Given the nature of our cross-sectional design, we could not elucidate the incidence of untreated and uncontrolled hypertension or other diseases. Future longitudinal studies should investigate these issues to develop a better health management system in Japanese occupational settings.

Our study showed lower age- and sex-specific prevalence of hypertension and obesity compared with those in the nationally representative sample of Japanese, which included the self-employed, the unemployed, and the housewife[@bib_022], [@bib_023]^)^. The national survey in 2013[@bib_022]^)^ showed that the prevalence of hypertension in individuals aged 20--29 years, 30--39 years, 40--49 years, 50--59 years, and 60--69 years were 11.6%, 17.9%, 32.9%, 56.4%, and 68.0% in men, and 1.8%, 5.7%, 16.4%, 34.7%, and 57.7% in women, respectively. The national survey in 2014[@bib_023]^)^ showed that the corresponding prevalence of obesity were 20.9%, 27.2%, 30.9%, 34.4%, 31.2%, respectively, in men, and 10.4%, 15.9%, 17.0%, 23.7%, and 24.0% in women, respectively. Further, a previous study using health checkup data in 2000 from five occupational health organizations[@bib_024]^)^ reported that, among men, prevalence of hypertension and obesity were slightly lower among workers in large-scale companies than those in small-scale enterprises. Thus, our finding of lower prevalence of hypertension and obesity than those in the national representative sample may be ascribed to the fact that our sample did not include workers in small and medium-sized enterprises. Although prevalence of dyslipidemia and metabolic syndrome in our sample were higher than those in the nationally representative sample[@bib_022], [@bib_025]^)^, this difference may be ascribed to the differences in the definition of the diseases (i.e., low HDL-cholesterol and self-report for dyslipidemia[@bib_022]^)^; abdominal obesity plus any one or more of the three conditions including high blood glucose, high blood pressure, and dyslipidemia for metabolic syndrome[@bib_025]^)^ in the national surveys). Previously, we reported similar age- and sex-specific prevalence of diabetes compared to those in nationally representative sample when using the same definition with HbA1c and self-report[@bib_008]^)^.

We found that the prevalence of no leisure-time exercise was high, especially in women. Although both male and female workers aged 60--69 years tended to engage in leisure-time exercise compared with younger workers, the prevalence of no exercise among workers aged 60--69 years exceeded 50% in men and 70% in women. This finding is supported by a recent national survey in Japan[@bib_013]^)^ showing similar age and sex difference in weekly sports time among workers. Additionally, another national survey of general population conducted in Japan in 2013 showed that the proportion of adults who did not engage in exercise (≥2 days per week of ≥30 min of exercise in a day for at least 1 year) was 66.2% in men and 72.8% in women[@bib_022]^)^. In addition, our results on the lower prevalence of no leisure-time exercise among workers aged 60--69 years compared with younger groups agree with this survey's findings[@bib_022]^)^. Given that women after menopause are at high risk of osteoporosis[@bib_026]^)^, physical activity promotion among middle-aged to older women would help to prevent this disease[@bib_027]^)^ and contribute to healthy life span. Given the decreasing trend of energy expenditure at work[@bib_028]^)^ and the high prevalence of no leisure-time exercise, workplace interventions for physical activity, including workstation interventions and promoting the use of stairs[@bib_029]^)^, may be a solution for maintaining or increasing regular physical activity level for Japanese workers.

In the present study, the prevalence of low fitness was 30--50% in men aged 20--59 years and approximately 20% in men aged 60--64 years. In women, the prevalence of low fitness was approximately 50--70% among workers aged 20--59 years, and approximately 30% in workers aged 60--64 years. However, only three women aged 60 to 64 years provided cardiorespiratory fitness data. Thus, any conclusion can be drawn for women aged 60 and over. The low prevalence of low fitness in men aged 60--64 years may be due to the selective inclusion of healthy workers, rather than a true prevalence; indeed, the proportion of those who did not provide cardiorespiratory fitness data increased with aging (data not shown). A previous study of Japanese workers showed that, compared with workers aged 50--59 years, workers aged 60--64 years and those aged 65 years and over tended to have lower fitness, although the proportion of women in each age group in that study is unclear[@bib_012]^)^. To minimize non-participation bias, measurement of grip strength, which is another indicator of fitness and can be assessed more simply, quickly, and inexpensively, and has been considered to be a promising biomarker of aging[@bib_030]^)^, may help stratify target individuals for intervention in occupational settings.

The strengths of this study include a large sample size and measurement of cardiorespiratory fitness, although fitness data were available only in a subgroup. However, there are limitations of our study. First, this study used existing data from more than 10 companies. Thus, questionnaires for lifestyles, history of disease, and medication, and the procedures for measuring anthropometric and biochemical data, were different by companies. All laboratories that conducted biochemical measurements for the participating companies, however, have participated in one or more external quality control programs and received the highest rank of certification. Second, although cancer[@bib_031]^)^ and mental health[@bib_032]^)^ in a working population are growing concerns in Japan, we did not systematically collect data on either of these factors. Future studies should elucidate the current situations of these issues among Japanese workers. In addition, we have no data on social class and occupation, and thus are not able to examine whether socioeconomic status is related to health among Japanese workers[@bib_033]^)^. Lastly, study participants were workers mainly from large-scale companies (electric machinery and apparatus manufacturing, steel, chemical, gas, non-ferrous metal manufacturing, automobile and instrument manufacturing, plastic product manufacturing). Therefore, the present findings may not be applicable to workers in small- to mid-sized companies, companies with different background, or general population in Japan.

We found that the prevalence of lifestyle-related risk factors including hypertension, diabetes, dyslipidemia, metabolic syndrome, and obesity was higher in men than women, and that the prevalence of these factors was high overall in workers aged 60--69 years. These findings reinforce the importance of developing effective strategies for the prevention of cardiovascular disease among middle-aged and older Japanese workers, especially in men. Regardless of age group, the prevalence of smoking exceeded 30% in men, whereas the prevalence of smoking was about 10% in women; smoking cessation and prevention of smoking initiation should be recommended, especially for men regardless of age. The prevalence of underweight was lowest among workers aged 60--69 years regardless of sex. Given the low proportion of workers who engaged in leisure-time exercise regardless of age or sex, physical activity promotion may yield large health benefits.
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